Related references
Note: Only part of the references are listed.Chemically induced models of Parkinson's disease
Thilaga Thirugnanam et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2022)
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
Nicolaas I. Bohnen et al.
LANCET NEUROLOGY (2022)
Altered Cholinergic Innervation in De Novo Parkinson's Disease with and without Cognitive Impairment
Sygrid van der Zee et al.
MOVEMENT DISORDERS (2022)
Optimizing 6-Hydroxydopamine Concentrations for induction of a Parkinson's Disease Like Behavior in Zebrafish
Adrian Romero et al.
FASEB JOURNAL (2022)
Chapter 5-Parkinson's disease - A role of non-enzymatic posttranslational modifications in disease onset and progression?
Sebastian Schmidt et al.
MOLECULAR ASPECTS OF MEDICINE (2022)
Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease
Dingyi Yu et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2021)
24-Epibrassinolide modulates the neurodevelopmental outcomes of high caffeine exposure in zebrafish (Danio rerio) embryos
Luis Felix et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2021)
Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology
Igor Pantic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
The Promise of the Zebrafish Model for Parkinson's Disease: Today's Science and Tomorrow's Treatment
Khairiah Razali et al.
FRONTIERS IN GENETICS (2021)
Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges
Md. Habibur Rahman et al.
MOLECULES (2021)
Effects of Holding Density on the Welfare of Zebrafish: A Systematic Review
Marica Andersson et al.
ZEBRAFISH (2021)
Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model
Rita L. Vaz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
6-Hydroxydopamine: a far from simple neurotoxin
Damir Vareslija et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death
Ali Farzam et al.
REDOX BIOLOGY (2020)
Promising Polyphenols in Parkinson's Disease Therapeutics
Ashish Singh et al.
NEUROCHEMICAL RESEARCH (2020)
The Aqueous Extract from Ceratonia siliqua Leaves Protects against 6-Hydroxydopamine in Zebrafish: Understanding the Underlying Mechanism
Sara Abidar et al.
ANTIOXIDANTS (2020)
An Update on Mitochondrial Reactive Oxygen Species Production
Ryan J. Mailloux
ANTIOXIDANTS (2020)
Modeling Parkinson's Disease in Zebrafish
Nor H. M. Najib et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2020)
24-Epibrassinolide protects against ethanol-induced behavioural teratogenesis in zebrafish embryo
Paulo Fernandes et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Function study of vasoactive intestinal peptide on chick embryonic bone development
Liu Shi et al.
NEUROPEPTIDES (2020)
All-age whole mountin situhybridization to reveal larval and juvenile expression patterns in zebrafish
Franz Vauti et al.
PLOS ONE (2020)
Parkinson's Disease-Induced Zebrafish Models: Focussing on Oxidative Stress Implications and Sleep Processes
Madalina-Andreea Robea et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Classic and evolving animal models in Parkinson's disease
Tanvi Pingale et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
RANKL biology: bone metabolism, the immune system, and beyond
Takehito Ono et al.
INFLAMMATION AND REGENERATION (2020)
Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae
Michael Kalyn et al.
BIOMEDICINES (2020)
Animal Models for Parkinson's Disease Research: Trends in the 2000s
Kyohei Kin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Automated Morphological Feature Assessment for Zebrafish Embryo Developmental Toxicity Screens
Elisabet Teixido et al.
TOXICOLOGICAL SCIENCES (2019)
Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review
Ranju Bansal et al.
MEDICINAL RESEARCH REVIEWS (2018)
Ketamine induction of p53-dependent apoptosis and oxidative stress in zebrafish (Danio rerio) embryos
Luis M. Felix et al.
CHEMOSPHERE (2018)
Novel models for Parkinson's disease and their impact on future drug discovery
Ines Trigo-Damas et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway
Maiquan Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Neuropathology of Parkinson disease
Dennis W. Dickson
PARKINSONISM & RELATED DISORDERS (2018)
Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies
Malgorzata Kujawska et al.
NUTRIENTS (2018)
N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae
Radharani Benvenutti et al.
PEERJ (2018)
Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review
Rita L. Vaz et al.
FRONTIERS IN NEUROLOGY (2018)
Steroids-specific target library for steroids target prediction
Xiaoxue Dang et al.
STEROIDS (2018)
Behavioral alterations of zebrafish larvae after early embryonic exposure to ketamine
Luis M. Felix et al.
PSYCHOPHARMACOLOGY (2017)
A Population of Indirect Pathway Striatal Projection Neurons Is Selectively Entrained to Parkinsonian Beta Oscillations
Andrew Sharott et al.
JOURNAL OF NEUROSCIENCE (2017)
Morphological and behavioral responses of zebrafish after 24 h of ketamine embryonic exposure
Luis M. Felix et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways
Chao Zhang et al.
REDOX BIOLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
ImageJ2: ImageJ for the next generation of scientific image data
Curtis T. Rueden et al.
BMC BIOINFORMATICS (2017)
Natural Products Combating Neurodegeneration: Parkinson's Disease
Md. Solayman et al.
CURRENT DRUG METABOLISM (2017)
Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease
Brigida R. Pinho et al.
PHARMACOLOGICAL RESEARCH (2016)
Spatial and Temporal Distribution of Dopaminergic Neurons during Development in Zebrafish
Yuchen Du et al.
FRONTIERS IN NEUROANATOMY (2016)
Ketamine-induced oxidative stress at different developmental stages of zebrafish (Danio rerio) embryos
Luis M. Felix et al.
RSC ADVANCES (2016)
Combined Oral Supplementation of Fish Oil and Quercetin Enhances Neuroprotection in a Chronic Rotenone Rat Model: Relevance to Parkinson's Disease
K. M. Denny Joseph et al.
NEUROCHEMICAL RESEARCH (2015)
From cutting edge to guideline: A first step in harmonization of the zebrafish embryotoxicity test (ZET) by describing the most optimal test conditions and morphology scoring system
Manon Beekhuijzen et al.
REPRODUCTIVE TOXICOLOGY (2015)
Oxidative stress and Parkinson's disease
Javier Blesa et al.
FRONTIERS IN NEUROANATOMY (2015)
Diving deeper into Zebrafish development of social behavior: Analyzing high resolution data
Christine Buske et al.
JOURNAL OF NEUROSCIENCE METHODS (2014)
Ketamine NMDA receptor-independent toxicity during zebrafish (Danio rerio) embryonic development
Luis M. Felix et al.
NEUROTOXICOLOGY AND TERATOLOGY (2014)
Long-Term Exposure to Paraquat Alters Behavioral Parameters and Dopamine Levels in Adult Zebrafish (Danio Rerio)
Josiane W. Bortolotto et al.
ZEBRAFISH (2014)
Effects of 6-Hydroxydopamine Exposure on Motor Activity and Biochemical Expression in Zebrafish (Danio Rerio) Larvae
Chien-Wei Feng et al.
ZEBRAFISH (2014)
Parkinson's disease: animal models and dopaminergic cell vulnerability
Javier Blesa et al.
FRONTIERS IN NEUROANATOMY (2014)
Spinal Projection Neurons Control Turning Behaviors in Zebrafish
Kuo-Hua Huang et al.
CURRENT BIOLOGY (2013)
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits
Miguel M. Carvalho et al.
MOLECULAR NEURODEGENERATION (2013)
Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish
Cheong-Meng Chong et al.
NEUROSCIENCE LETTERS (2013)
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Sudhakar Raja Subramaniam et al.
PROGRESS IN NEUROBIOLOGY (2013)
The Spinning Task: A New Protocol to Easily Assess Motor Coordination and Resistance in Zebrafish
Ana R. Blazina et al.
ZEBRAFISH (2013)
Animal models of Parkinson's disease
Fabio Blandini et al.
FEBS JOURNAL (2012)
Mitochondria, oxidative stress and neurodegeneration
Antonio Federico et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Brassinosteroids and analogs as neuroprotectors: Synthesis and structure-activity relationships
Jihane Ismaili et al.
STEROIDS (2012)
Motor Control Abnormalities in Parkinson's Disease
Pietro Mazzoni et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
24-Epibrassinolide, a Phytosterol from the Brassinosteroid Family, Protects Dopaminergic Cells against MPP+ - Induced Oxidative Stress and Apoptosis
Julie Carange et al.
JOURNAL OF TOXICOLOGY (2011)
Acetylcholine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Deranda B. Lester et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
Kristen A. Malkus et al.
MOLECULAR NEURODEGENERATION (2009)
Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and -independent action
Yoshiro Saito et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
R Iancu et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
p-quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly
Y Izumi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
6-hydroxydopamine-induced developmental cardiac alterations in morphology, calmodulin content, and K+-mediated [Ca2+]i transient of chicken cardiomyocytes
AKS Ho et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants:: Potential implication in relation to the pathogenesis of Parkinson's disease
R Soto-Otero et al.
JOURNAL OF NEUROCHEMISTRY (2000)